Vdex a $mnkd shareholder with few offices seem to only give afrezza not sound diabetes care say it's in talks about selling afrezza in nations it's not approved. vdex requires investigation on many levels. @US_FDA#FDA @FDA_ORA https://t.co/1oI1vYYHBK @AGBecerra@SEC_Enforcement
$mnkd Looks like the ADA conference presentation pump re: technosphere being better than aspart insulin is a repeat of Last years STAT study where afrezza arm got to make two dose corrections while aspart arm didn't amongst other flaws.
@SEC_Enforcement watch $MNKD for possible #REAL_TIME stock pumper manipulation. @US_FDA#FDA Office of Prescription Drug Promotion watch $mnkd social media for false and misleading claims denying risks and dangers of Black Box afrezza. Thank You.
@simonning1 Not standard boilerplate statement about their doubts to continue. Only companies in severe financial distress would tell partner that. Scripts are horrible as they have been for 5 years.
Appalling scripts after5 yrs but execs will get their salary increase. I did make a $mnkd decal for son's race car bed. I like this laura video.
How to Get Your Parents to Homeschool You https://t.co/r24b0EHvQw via @YouTube
$mnkd A better video from the afrezza shill laura who said in Aril 2016 ""I am thrilled to work with MannKind" 21 Valentine's Day Facts https://t.co/77JIHVBV48 via @YouTube
@schlimeel@YouTube From FDA document on Afrezza: Trials in type1 diabetes demonstrate that Afrezza provides numerically and statistically less HbA1c reduction than a comparator subcutaneous insulin.
I like this one
How to Get Your Parents to Homeschool You https://t.co/r24b0EHvQw via @YouTube
5 years and Afrezza Nrx for 3/2/2019 a feeble 325 refill rate insignificant at 308 $mnkd so imperceptible in diabetes space. Biggest drug flop of all time.
MNKD's 10K shows the complete collapse of it's pps since Afrezza was narrowly approved 5 yrs ago. The drug is a utter failure. NRx on 2/15/19 =285. BP has 0 interest in this trash. Longy is delusional about Mikey's smoke & mirror show & periodic dead cat bounces. $mnkd #afrezza
Speaking of pediatric trails $MNKD has been trying to recruit 46 patients for it since 2015. It's still recruiting..Doubt it'll finish study since this dying company has severe money problems.
Pathetic longs exploiting their kids with pictures of them in pediatric trials of dud drug afrezza. Sad. Of course could just be a post from $MNKD IT dept.
@adamfeuerstein Arena management needs to try to stop this. I've seen on censored iv arna discussion bd that these cult members send letters to Big Pharma also. Such sad desperate people
Here we go again… $ARNA retail investor cult — still clinging to company from Belviq days — has been sending letters to investors/analysts, making wildly promotional and irresponsible claims about Arena. Unfortunate, right ahead of etrasimod data readout.